CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 3,786 shares at $55.62 ($210,577)
- 4 Open-market sale General Counsel and Secretary sold 3,182 shares at $46.78 ($148,854)
- 4 Open-market sale Chief Executive Officer sold 10,020 shares at $46.78 ($468,736)
- 4 Open-market sale Chief Financial Officer sold 3,708 shares at $46.78 ($173,460)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 3,150 shares at $48.26 ($152,019)
- 4 Open-market sale Chief Financial Officer sold 9,869 shares at $48.26 ($476,278)
- 4 Open-market sale General Counsel and Secretary sold 3,450 shares at $48.26 ($166,497)
- 4 Open-market sale Chief Executive Officer sold 10,349 shares at $48.26 ($499,443)
- 4 Open-market sale General Counsel and Secretary sold 2,800 shares at $52.80 ($147,840)
Page 2 of 26 · 502 filings